Imitrex News
Ranbaxy, GSK settle Imitrex patent dispute - Business Standard
Ranbaxy Laboratories has settled a patent litigation in the US with drug major GlaxoSmithKline (GSK) relating to Imitrex (sumatriptan succinate tablets), ...
GSK deal to net Ranbaxy $90 mn in ’09 - Livemint
Dr Reddy’s had said in October 2006 that it had been signed on by GSK as the authorized generics partner on Imitrex, the migraine drug whose patent expires ...
Ranbaxy, GSK settle Imitrex patent issue - Times of India
Sumatriptan Succinate tablets are the generic version of GlaxoSmithKline’s Imitrex Tablets. The terms of the settlement, provide that Ranbaxy may distribute ...
India's Ranbaxy says settles issues with GSK over generic Imitrex ... - CNNMoney.com
all 30 news articles
Mother, Boyfriend Charged With Infant's Drowning - Tyler Morning Telegraph
After searching the apartment police found 182 Oxycodone pills, 87 Methadone pills, 96 Vicodine pills, 30 Xanax pills, 14 Imitrex pills and five ...
Pozen makes deadline for FDA - News & Observer
Imitrex, which generated $1.3 billion in sales for GSK in 2006, will face competition from generic versions by the end of this year. ...
Pozen making progress on migraine drug - News & Observer
Imitrex, which generated $1.3 billion in sales for GSK in 2006, will face competition from generic versions by the end of this year. ...
TASE opens positively - Globes
According to IMS sales data for the US, Imitrex had $910 million in sales in the 12 months through September 2007. Teva is up 0.4% Real estate stocks are ...
Teva gains UK authorisation for generic - Life Style Extra
In 2006, Glaxo reported worldwide sales for sumatriptan-based Imigran and Imitrex, one of its top ten pharmaceutical products, of 711 mln stg, ...
TASE opens positively - Globes
According to IMS sales data for the US, Imitrex had $910 million in sales in the 12 months through September 2007. Teva is up 0.4% Real estate stocks are ...
Imitrex RSS Feed